Medications for Breast Cancer, Metastatic
Other names: Metastatic Breast Cancer
Drugs used to treat Breast Cancer, Metastatic
The following list of medications are in some way related to or used in the treatment of this condition.
Drug name | Rating | Reviews | Activity ? | Rx/OTC | Pregnancy | CSA | Alcohol |
---|---|---|---|---|---|---|---|
Ibrance | 6.7 | 61 reviews | Rx | ||||
Generic name: palbociclib systemic Drug class: CDK 4/6 inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
letrozole | 7.0 | 26 reviews | Rx | ||||
Generic name: letrozole systemic Brand name: Femara Drug class: hormones/antineoplastics, aromatase inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
Femara | 7.0 | 8 reviews | Rx | ||||
Generic name: letrozole systemic Drug class: hormones/antineoplastics, aromatase inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
anastrozole | 6.4 | 9 reviews | Rx | ||||
Generic name: anastrozole systemic Brand name: Arimidex Drug class: hormones/antineoplastics, aromatase inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
Faslodex | 6.6 | 23 reviews | Rx | ||||
Generic name: fulvestrant systemic Drug class: hormones/antineoplastics, estrogen receptor antagonists For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Arimidex | 6.0 | 4 reviews | Rx | ||||
Generic name: anastrozole systemic Drug class: hormones/antineoplastics, aromatase inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Xeloda | 4.5 | 13 reviews | Rx | ||||
Generic name: capecitabine systemic Drug class: antimetabolites For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
fulvestrant | 5.9 | 28 reviews | Rx | ||||
Generic name: fulvestrant systemic Brand name: Faslodex Drug class: hormones/antineoplastics, estrogen receptor antagonists For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
Herceptin | 10 | 2 reviews | Rx | ||||
Generic name: trastuzumab systemic Drug class: HER2 inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
palbociclib | 6.7 | 68 reviews | Rx | ||||
Generic name: palbociclib systemic Brand name: Ibrance Drug class: CDK 4/6 inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph |
|||||||
tamoxifen | 3.0 | 2 reviews | Rx | ||||
Generic name: tamoxifen systemic Brand name: Soltamox Drug class: hormones/antineoplastics, selective estrogen receptor modulators For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
bevacizumab Off-label | 9.0 | 3 reviews | Rx | ||||
Generic name: bevacizumab systemic Drug class: VEGF/VEGFR inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph Off-label: Yes |
|||||||
Enhertu | Rate | Add review | Rx | ||||
Generic name: fam-trastuzumab deruxtecan systemic Drug class: HER2 inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
capecitabine | 5.3 | 19 reviews | Rx | ||||
Generic name: capecitabine systemic Brand name: Xeloda Drug class: antimetabolites For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
fam-trastuzumab deruxtecan | Rate | Add review | Rx | ||||
Generic name: fam-trastuzumab deruxtecan systemic Brand name: Enhertu Drug class: HER2 inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph |
|||||||
Tykerb | Rate | Add review | Rx | ||||
Generic name: lapatinib systemic Drug class: EGFR inhibitors, HER2 inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Taxotere | 9.0 | 1 review | Rx | ||||
Generic name: docetaxel systemic Drug class: mitotic inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Abraxane | 0.0 | 1 review | Rx | ||||
Generic name: paclitaxel protein-bound systemic Drug class: mitotic inhibitors For consumers: dosage, interactions, side effects |
|||||||
Halaven | 9.4 | 8 reviews | Rx | ||||
Generic name: eribulin systemic Drug class: mitotic inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Gemzar | 7.0 | 1 review | Rx | ||||
Generic name: gemcitabine systemic Drug class: antimetabolites For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Perjeta | Rate | Add review | Rx | ||||
Generic name: pertuzumab systemic Drug class: HER2 inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
trastuzumab | 10 | 2 reviews | Rx | ||||
Generic name: trastuzumab systemic Brand names: Herceptin, Herzuma, Kanjinti, Ogivri, Ontruzant, Trazimera …show all Drug class: HER2 inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph |
|||||||
docetaxel | 5.0 | 2 reviews | Rx | ||||
Generic name: docetaxel systemic Brand name: Taxotere Drug class: mitotic inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
eribulin | 8.7 | 10 reviews | Rx | ||||
Generic name: eribulin systemic Brand name: Halaven Drug class: mitotic inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph |
|||||||
Ixempra | Rate | Add review | Rx | ||||
Generic name: ixabepilone systemic Drug class: mitotic inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Learn more about Breast Cancer, Metastatic
Care guides
Symptoms and treatments
Legend
Rating | For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). |
---|---|
Activity | Activity is based on recent site visitor activity relative to other medications in the list. |
Rx | Prescription only. |
OTC | Over-the-counter. |
Rx/OTC | Prescription or Over-the-counter. |
Off-label | This medication may not be approved by the FDA for the treatment of this condition. |
EUA | An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives. |
Pregnancy Category | |
---|---|
A | Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
C | Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. |
N | FDA has not classified the drug. |
Controlled Substances Act (CSA) Schedule | |
---|---|
M | The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication. |
U | CSA Schedule is unknown. |
N | Is not subject to the Controlled Substances Act. |
1 | Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. |
2 | Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
3 | Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
4 | Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
5 | Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
Alcohol | |
---|---|
X | Interacts with Alcohol. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.